Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $98
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $108 to $98.
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and lowers the price target from $108 to $98.